NcXHF

ARMENIAN, KREMER, AND SKLAR
59. Oeffınger KC, Adams-Huet B, Victor RG, et al. Insulin resistance and
risk factors for cardiovascular disease in young adult survivors of childhood
acute lymphoblastic leukemia. J Clin Oncol. 2009;27:3698-3704.
60. Armstrong GT, Oeffınger KC, Chen Y, et al. Modifıable risk factors and
major cardiac events among adult survivors of childhood cancer. J Clin
Oncol. 2013;31:3673-3680.
61. van Dalen EC, Caron HN, Dickinson HO, et al. Cardioprotective interventions
for cancer patients receiving anthracyclines. Cochrane Database
Syst Rev. 2008:CD003917.
62. Lipshultz SE, Scully RE, Lipsitz SR, et al. Assessment of dexrazoxane as
a cardioprotectant in doxorubicin-treated children with high-risk acute
lymphoblastic leukaemia: long-term follow-up of a prospective, randomised,
multicentre trial. Lancet Oncol. 2010;11:950-961.
63. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in
survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor
Study. J Clin Endocrinol Metab. 2000;85:3227-3232.
64. Chow EJ, Friedman DL, Stovall M, et al. Risk of thyroid dysfunction and
subsequent thyroid cancer among survivors of acute lymphoblastic leukemia:
a report from the Childhood Cancer Survivor Study. Pediatr
Blood Cancer. 2009;53:432-437.
65. Laughton SJ, Merchant TE, Sklar CA, et al. Endocrine outcomes for children
with embryonal brain tumors after risk-adapted craniospinal and
conformal primary-site irradiation and high-dose chemotherapy with
stem-cell rescue on the SJMB-96 trial. J Clin Oncol. 2008;26:1112-1118.
66. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of
Hodgkin’s disease. N Engl J Med. 1991;325:599-605.
67. Boulad F, Bromley M, Black P, et al. Thyroid dysfunction following
bone marrow transplantation using hyperfractionated radiation. Bone
Marrow Transplant. 1995;15:71-76.
68. Picco P, Garaventa A, Claudiani F, et al. Primary hypothyroidism and
131I-MIBG therapy in neuroblastoma. Lancet. 1993;342:57.
69. van Santen HM, de Kraker J, van Eck BL, et al. High incidence of thyroid
dysfunction despite prophylaxis with potassium iodide during (131)Imeta-iodobenzylguanidine
treatment in children with neuroblastoma.
Cancer. 2002;94:2081-2089.
70. Laverdière C, Cheung NK, Kushner BH, et al. Long-term complications
in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer.
2005;45:324-332.
71. Bhandari S, Cheung NK, Kushner BH, et al. Hypothyroidism after 131Imonoclonal
antibody treatment of neuroblastoma. Pediatr Blood Cancer.
2010;55:76-80.
72. Torino F, Corsello SM, Longo R, et al. Hypothyroidism related to tyrosine
kinase inhibitors: an emerging toxic effect of targeted therapy.
Nat Rev Clin Oncol. 2009;6:219-228.
73. Chemaitilly W, Sklar CA. Endocrine complications of hematopoietic
stem cell transplantation. Endocrinol Metab Clin North Am. 2007;36:
983-998;ix.
74. Chemaitilly W, Sklar CA. Endocrine complications in long-term survivors
of childhood cancers. Endocr Relat Cancer. 2010;17:R141-R159.
75. Green DM, Kawashima T, Stovall M, et al. Fertility of male survivors of
childhood cancer: a report from the Childhood Cancer Survivor Study.
J Clin Oncol. 2010;28:332-339.
76. Kenney LB, Cohen LE, Shnorhavorian M, et al. Male reproductive
health after childhood, adolescent, and young adult cancers: a report
from the Children’s Oncology Group. J Clin Oncol. 2012;30:3408-3416.
77. Green DM, Liu W, Kutteh WH, et al. Cumulative alkylating agent
exposure and semen parameters in adult survivors of childhood cancer:
a report from the St, Jude Lifetime Cohort Study. Lancet Oncol.
2014;15:1215-1223.
78. Green DM, Zhu L, Zhang N, et al. Lack of specifıcity of plasma concentrations
of inhibin B and follicle-stimulating hormone for identifıcation
of azoospermic survivors of childhood cancer: a report from the St. Jude
lifetime cohort study. J Clin Oncol. 2013;31:1324-1328.
79. Sklar C. Reproductive physiology and treatment-related loss of sex hormone
production. Med Pediatr Oncol. 1999;33:2-8.
80. Shalet SM, Horner A, Ahmed SR, et al. Leydig cell damage after testicular
irradiation for lymphoblastic leukaemia. Med Pediatr Oncol. 1985;
13:65-68.
81. Metzger ML, Meacham LR, Patterson B, et al. Female reproductive
health after childhood, adolescent, and young adult cancers: guidelines
for the assessment and management of female reproductive complications.
J Clin Oncol. 2013;31:1239-1247.
82. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the
childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91:
1723-1728.
83. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors
of childhood cancer: a report from the childhood cancer survivor
study. J Natl Cancer Inst. 2006;98:890-896.
84. Michel G, Socié G, Gebhard F, et al. Late effects of allogeneic bone marrow
transplantation for children with acute myeloblastic leukemia in
fırst complete remission: the impact of conditioning regimen without
total-body irradiation—a report from the Société Française de Greffe de
Moelle. J Clin Oncol. 1997;15:2238-2246.
85. Green DM, Sklar CA, Boice JD Jr, et al. Ovarian failure and reproductive
outcomes after childhood cancer treatment: results from the Childhood
Cancer Survivor Study. J Clin Oncol. 2009;27:2374-2381.
86. Barton SE, Najita JS, Ginsburg ES, et al. Infertility, infertility treatment,
and achievement of pregnancy in female survivors of childhood cancer:
a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol.
2013;14:873-881.
87. Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female
survivors of childhood cancer: a report from the Childhood Cancer Survivor
Study. Am J Obstet Gynecol. 2002;187:1070-1080.
88. Signorello LB, Mulvihill JJ, Green DM, et al. Stillbirth and neonatal
death in relation to radiation exposure before conception: a retrospective
cohort study. Lancet. 2010;376:624-630.
89. Signorello LB, Mulvihill JJ, Green DM, et al. Congenital anomalies in the
children of cancer survivors: a report from the childhood cancer survivor
study. J Clin Oncol. 2012;30:239-245.
90. Winther JF, Olsen JH, Wu H, et al. Genetic disease in the children of
Danish survivors of childhood and adolescent cancer. J Clin Oncol.
2012;30:27-33.
91. Lie Fong S, Visser JA, Welt CK, et al. Serum anti-müllerian hormone
levels in healthy females: a nomogram ranging from infancy to adulthood.
J Clin Endocrinol Metab. 2012;97:4650-4655.
92. Armenian SH, Bhatia S. Chronic health conditions in childhood cancer
survivors: is it all treatment-related—or do genetics play a role? J Gen
Intern Med. 2009;24:S395-S400 (suppl 2).
204 2015 ASCO EDUCATIONAL BOOK | asco.org/edbook